Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4Neoplasm Metastasis 4Colorectal Neoplasms 4Immunotherapy Gastrict Cancer 1HER-2 Negatived Gastric Cancer 1Gastrointestinal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Advanced NSCLC With EGFR Mutation 1Advanced Gastric Cancer 1Advanced Gastric Adenocarcinoma 1

Interventions

camrelizumab 2spartalizumab 1apatinib 1S 1 (combination) 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Advanced Gastric Adenocarcinoma × S 1 (combination) × Clear all
NCT04675866 2022-04-15

Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer

Henan Cancer Hospital

Phase NA Unknown
46 enrolled
Gastrointestinal

Advanced Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡